Teza Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,941
| Closed | -$215K | – | 455 |
|
|
2025
Q1 | $215K | Buy |
5,941
+84
| +1% | +$3.04K | 0.1% | 344 |
|
|
2024
Q4 | $246K | Buy |
5,857
+993
| +20% | +$41.8K | 0.04% | 397 |
|
|
2024
Q3 | $270K | Buy |
+4,864
| New | +$270K | 0.03% | 499 |
|
|
2024
Q2 | – | Sell |
-5,293
| Closed | -$247K | – | 726 |
|
|
2024
Q1 | $247K | Buy |
+5,293
| New | +$247K | 0.03% | 475 |
|
|
2023
Q1 | – | Sell |
-6,707
| Closed | -$311K | – | 674 |
|
|
2022
Q4 | $311K | Buy |
+6,707
| New | +$311K | 0.06% | 438 |
|